Astrazeneca PLC Stock Quote & Summary Data
*Delayed - data as of May 24, 2013 12:24 ET
Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
Symbol Lookup
Log in or Register
Save stocks for next time
| Sponsored
Dynamic quotes: Off
|
ETFs with AZN as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 4.76% | Merrill Lynch Pharmaceutical HOLDRS (PPH) | +8.03 (20.41%) |
| 1.98% | BLDRS Europe 100 ADR Index Fund (ADRU) | +1.04 (4.97%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
The information (including tabular data) set forth under the headings “Additional Information—Corporate Information—History and development of the Company” on page 208, “Performance—Financial Review—Financial position – 2012—Investments, divestments and capital expenditure” on page 93 and “Financial Statements—Notes to the Group Financial Statements—Note 22—Acquisitions and disposals” on pages 173 to 174, in each case of the Company’s “Annual Report and Form 20-F Information 2012” included as exhibit 15.1 to this Form 20-F dated March 25, 2013 is incorporated by reference. B. ... More ...
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $6.86 |
| Quarterly EPS Est: | 1.27 |
| PEG Ratio: | -1.93 |
|
Mean Recommendation: View Summary / View All |
3.13 |
Data is provided by Zacks Investment Research